Articles related to MEN'S HEALTH

This study challenges the conventional reliance on BCR as a primary end point in prostate cancer trials, emphasizing the need for a more comprehensive approach that includes overall survival rates.

This meta-analysis provides a comprehensive look at the factors affecting testosterone levels in men, highlighting the importance of considering age, lifestyle, and health conditions for accurate diagnosis.

New research reveals significant differences in overall survival rates based on the site of visceral metastases in metastatic prostate cancer. Discover how these insights could shape your approach to patient care.

The ASCO 2023 meeting has unveiled key studies in prostate cancer, including insights into PSA levels post-radiation therapy, the role of BRCA mutations, and promising combination therapies.

The FDA’s approval of the olaparib, abiraterone, and prednisone regimen for BRCA-mutated mCRPC, based on the PROpel trial, could significantly alter the treatment landscape. Learn more about this promising development in prostate cancer therapy.

This study urges a re-evaluation of surrogate endpoints in advanced prostate cancer, questioning the validity of commonly used markers and calling for further research in predicting overall survival.